Global Antihypertensive Trends in 2022
Antihypertensive is part of Cardiovascular Drug. You may also be interested in Anticoagulant, Heart Drug and ACE Inhibitor.
Global antihypertensive medicine sales are expected to reach $1.4 billion by 2026, up from $1.4 billion in 2021. On average, demand has grown by 0.8% year-on-year since 2017. Germany is the largest regional market for antihypertensive medicines, with sales of $406 million in 2021. Italy, Spain and Australia followed in second, third and fourth place respectively. Spain saw the highest growth, with a 29.8% year-on-year increase since 2017. Italy's demand, meanwhile, decreased by 3%.
Top 10 countries
In 2022 major markets in the Antihypertensive Industry were:
Antihypertensive Market Data and Forecasts
How much the Antihypertensive industry is expected to grow to 2026?
More in Antihypertensive Industry for 2028Global Antihypertensive Industry Database
Improve your Knowledge with the latest Indicators and Trends
-
Pharmaceutical Landscape: Uncovering Trends and Opportunities in Global Anticoagulants Market
The anticoagulants market is witnessing a surge in its growth trajectory, primarily driven by demographic changes such as an aging population, which is increasing the demand for these drugs. The rise in prevalence of cardiovascular diseases and lifestyle-related ailments leading to blood clot formation fuels the need for anticoagulants, further...
Discover more insights -
Antihyperlipidemic Drugs: Unpacking Industry Developments and Key Market Trends
The field of drugs treating elevated lipid levels, traditionally occupied by statins, has seen considerable progress. New classes, such as PCSK9 inhibitors and mRNA-based therapies, are currently being developed and commercialized. These innovative treatments promise to augment the therapeutic landscape and enhance patient outcomes, especially for those resistant or intolerant...
Discover more insights -
Exploring Anti-Hypertensive Drugs Markets: Trends, Challenges, and Competitive Analysis
The anti-hypertensive drugs market is marked by several notable trends, fuelled by globally escalating hypertension prevalence. As per recent forecasts, the sector is anticipated to exhibit steady growth, spurred by a rising pool of geriatric population at risk of high blood pressure. Increasing health awareness and advancements in drug discovery...
Discover more insights